Infervision is a leading global high-tech enterprise in medical artificial intelligence. Aiming to empower doctors with higher efficiency and benefit patients with better diagnosis, outcome and lower cost, Infervision is using A.I. and deep learning technologies to develop multiple platforms, including an A.I. applications management platform, an A.I. data-mining research platform, and several A.I. clinical application platforms, as well as medical A.I. systems for quality control, health management, and scientific research.

As of June 2019, Infervision has service covering North America, Asia-Pacific, China and Europe regions, with its presence in nine countries worldwide, and has assisted in processing over 13 million accumulated cases. Infervision’s medical A.I. solutions are rapidly becoming the most utilized systems worldwide.

Infervision’s scientists and engineering teams have successfully launched the Coronavirus AI solution in Wuhan China and specially tailored it for front-line use to help clinicians detect and monitor the disease efficiently and effectively.

Infervision’s Coronavirus AI solution has been in use at the center of the epidemic outbreak at Tongji Hospital in Wuhan (Tongji Medical College of Huazhong University of Science & Technology), along with sites in other cities such as the Third People’s Hospital of Shenzhen in Shenzhen City. Infervision’s Coronavirus AI solution is accelerating pneumonia diagnosis and epidemic monitoring efforts.

Company Type: Startup

Region: US & Canada

Industry Category: Healthcare Covid 19

Product: AI Solutions